Re-assessment of the Actual Benefit following the instruction of 7 May 2011 from the Directorate of Social Security and Directorate-General for Health and renewal of inclusion on the list of medicines refundable by National Health Insurance.
Clinical Benefit
Substantial
Le service médical rendu par les spécialités ALPRESS LP 2,5 mg et 5 mg reste important.